Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001398432-15-000317
Filing Date
2015-08-18
Accepted
2015-08-18 17:01:50
Documents
9
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 i12803.htm 10-Q 327405
2 exh31_1.htm EX-31.1 10025
3 exh32_1.htm EX-32.1 3179
  Complete submission text file 0001398432-15-000317.txt   2675068

Data Files

Seq Description Document Type Size
4 nphc-20150630.xml EX-101.INS 416064
5 nphc-20150630.xsd EX-101.SCH 35642
6 nphc-20150630_cal.xml EX-101.CAL 44464
7 nphc-20150630_def.xml EX-101.DEF 99811
8 nphc-20150630_lab.xml EX-101.LAB 259759
9 nphc-20150630_pre.xml EX-101.PRE 197651
Mailing Address 12502 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12502 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

EIN.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32141 | Film No.: 151062001
SIC: 2833 Medicinal Chemicals & Botanical Products